Investigating the Genetic Cause of Ichthyosis Disease in a Family with Exome Sequencing

authors:

avatar Farzaneh Ghalavandi 1 , avatar Zahra Khoshnood 1 , *

Department of Biology, Dezful Branch, Islamic Azad University, Dezful, Iran

how to cite: Ghalavandi F, Khoshnood Z. Investigating the Genetic Cause of Ichthyosis Disease in a Family with Exome Sequencing. Gene Cell Tissue. 2024;11(3):e146213. https://doi.org/10.5812/gct-146213.

Abstract

Background:

Ichthyosis is a diverse skin disease characterized by dry skin and itching, particularly affecting the hands. Most forms of this condition are hereditary.

Objectives:

In this study, we investigated potential new mutations associated with this disease using the new technique of whole-exome sequencing.

Methods:

In this study, after collecting the patient's blood sample in an EDTA tube and extracting DNA using the salting-out method, next-generation sequencing was performed using the WES method. Following the analysis of the results and identification of the candidate gene, PCR technique and Chromas software were used to confirm the findings.

Results:

The results indicated the presence of a new variant, NM_001099287: Exon 6:c.C1083A: p.Y361X, in the NIPAL4 gene in a heterozygous form in the parents and a homozygous form in the patient. This variant occurred as a nucleotide substitution in the exon 6 region of the NIPAL4 mRNA sequence.

Conclusions:

Using the WES technique, it is possible to investigate the presence of new variants related to ichthyosis in a short time and at a low cost.

1. Background

Ichthyosis refers to a group of skin disorders that can occur in both hereditary and acquired forms in individuals. This disorder results in a deficiency in the differentiation of keratinocytes and an abnormal structure of epidermal cells (1). Ichthyosis is classified into three groups based on genetic factors:

- Autosomal Dominant Group: This group includes Ichthyosis vulgaris, Lamellar ichthyosis, Refsum syndrome, and Sjögren-Larsson syndrome. These conditions follow an autosomal dominant inheritance pattern.

- Gender-Dependent Dominant Group: A type of ichthyosis that follows a gender-dependent dominant pattern.

- Autosomal Recessive Group: This group includes Ichthyosis Vulgaris bullosa and, rarely, Hystrix ichthyosis. These conditions follow an autosomal recessive inheritance pattern (2).

Despite the existence of various disease types, common symptoms in all forms of ichthyosis include itching, recurrent infections, sweating disorders (hypohidrosis) accompanied by heat intolerance, and various ocular, auditory, and nutritional complications (3, 4). In recent years, significant advances have been made in understanding the pathophysiology of ichthyosis (5, 6). Studies indicate that mutations in more than 40 genes can lead to the ichthyosis phenotype (7, 8). However, diagnosing the disease based solely on clinical symptoms and histopathological lesions is not precise enough to identify the molecular cause (9).

Next-generation sequencing (NGS) technology, specifically whole-exome sequencing (WES), makes it possible to sequence all coding protein regions as well as exonic-intronic boundary regions. This high-efficiency technique enables the identification of the molecular basis of many genetic disorders (10, 11).

Our research aims to explore the molecular dimensions of ichthyosis using cutting-edge WES technology. By scrutinizing carriers genetically, we can identify the underlying factors of genetic skin disorders and inhibit the propagation of harmful mutations to succeeding generations. Crafting an exome test panel covering all pertinent genes linked to these skin ailments enables a precise, swift, and economical molecular diagnosis.

2. Objectives

This represents a notable advancement in our pursuit to analyze and comprehend the genetic complexities of skin disorders efficiently and with the utmost precision possible.

3. Methods

In this cross-sectional study, we investigated a family with a diseased child and seven of their relatives who visited the Noorgene Medical Genetics Laboratory during the years 2022 - 2023. Entry into the study required meeting specific criteria, including confirmation of clinical manifestations related to ichthyosis by a specialist physician and obtaining consent from the research participants. After collecting clinical data and providing genetic counseling, we constructed a family pedigree (Figure 1).

Genealogy of the studied family. The daughter of the target family is suffering from ichthyosis.
Genealogy of the studied family. The daughter of the target family is suffering from ichthyosis.

We collected 5 milliliters of the patient's peripheral blood in a 0.5% EDTA tube and performed DNA extraction using the salting-out method. Quantitative and qualitative assessments of DNA quality were conducted using a nanodrop device and electrophoresis on agarose gel. Genome sequencing was carried out using the Illumina HiSeq 2500 platform. The analyzed data were then validated against the pedigree pattern using the Sanger sequencing standard method.

For PCR execution, we added 10 microliters of Red Mix solution, 8 microliters of double-distilled water, 2 microliters of the DNA sample, and 0.5 microliters each of forward and reverse primers to the reaction tube. The primers used in the research are detailed in Table 1. The PCR products underwent electrophoresis (Figure 2). Finally, the PCR products were sequenced using the ABI 3130XL sequencing instrument, and the results were analyzed using Chromas software on the NCBI and ENSEMBL websites.

Table 1.

Sequence of Primers Used for PCR Reaction of NIPAL4 Gene

PrimerSequence
NIPAL4-EX6-F-399GGG CAA AGG AAT ATC CTC ATC TAC
NIPAL4-EX6-R-399GCA GCT GAT GTC CAG GTC TT
Electrophoresis of PCR products
Electrophoresis of PCR products

4. Results

In this study, we examined a family from Khuzestan province along with seven of their relatives. After analyzing the results and constructing the pedigree, we assessed the type of mutation present in the family. Within this family, a diseased daughter exhibiting phenotypic symptoms of ichthyosis was identified and confirmed by a dermatologist. The pedigree analysis revealed that other family members and relatives were asymptomatic.

Whole Exome Sequencing (WES) results identified 256,987 variants, which were further filtered based on zygosity and allele frequency in the population. This process led to the identification of a variant as a candidate molecular factor in the disease. The specific mutation, NM_001099287.2: Exon 6:c.C897A:p.Ter361Ter, is located in the NIPAL4 gene at the chromosomal location 5q33. This variant, situated in exon 6 at codon 1083, is normal in the CC state, diseased in the AA state, and heterozygous in the AC state, indicating carrier status for the individual (see Figure 3).

NIPAL4 gene sequence sequence. The sequence of A and B shows the sequence of the patient's parents, which is heterozygous, and the sequence of part C shows the sequence of the patient, which is homozygous
NIPAL4 gene sequence sequence. The sequence of A and B shows the sequence of the patient's parents, which is heterozygous, and the sequence of part C shows the sequence of the patient, which is homozygous

5. Discussion

Ichthyoses represent a heterogeneous group of keratinization disorders characterized by genotypic and phenotypic abnormalities, resulting in continuous shedding of the skin due to improper epidermal layering (12). Given that ichthyoses follow several inheritance patterns, the candidate gene identified for the studied family is NIPAL4, inherited in an autosomal recessive manner. Autosomal Recessive Congenital Ichthyosis (ARCI) is caused by functional defects in epidermal barrier components, including the intercellular lipid barrier, cornified cell envelope, and keratin breakdown products, leading to chronic scaling and skin roughness. In most cases of ARCI, skin dryness, fissures, and occasional itching are also reported. ARCI can be particularly life-threatening in the first year of life due to severe skin inflammation, hypothermia, and dehydration (13). This disease, which can be inherited as a distinct trait or as part of a syndrome in combination with other abnormal manifestations, has a prevalence of less than 1 in 200,000 and manifests due to mutations in several genes (14). Based on our study, comprehensive genetic exploration focusing on the NIPAL4 family of genes involved in skin diseases has not been conducted in Iran to date, with only limited studies addressing the investigation of different inheritance patterns of the disease. Next-Generation Sequencing (NGS) techniques are highly valuable tools for detecting genodermatoses (disorders that can manifest specifically in the skin), including ichthyoses (15). Between 2009 and 2019, NGS has aided in identifying 166 gene relationships related to skin diseases and 63 cases of complex genodermatoses caused by multiple gene mutations (16). In 2018, Sitek and colleagues proposed the use of Whole Exome Sequencing (WES) as the primary diagnostic method for ichthyosis after studying 34 suspected cases over a three-year period (17). Therefore, it appears that by employing new techniques, a fundamental revolution in understanding and diagnosing skin disorders, including ichthyoses, is underway.

Charfeddine et al.'s in silico analysis demonstrated that mutations in the 3D domain structure lead to NIPAL4 protein instability and impaired Mg2+ transport, pointing to the potential role of the NIPAL4 gene in the development and maintenance of epidermal barrier function. Collectively, the results of their study strengthened NIPAL4 as the main candidate gene for the EKV-like Autosomal Recessive Congenital Ichthyosis (ARCI) phenotype (18).

The use of acellular scaffolds can be an important step in the treatment of skin diseases such as ichthyosis (19).

This research aims to effectively identify new mutations in the NIPAL4 gene, responsible for a familial skin disease, through the use of advanced and effective techniques. Identifying disease-causing mutations will help reveal the genetic structure of this disease and subsequently enhance preventive and counseling methods significantly. Furthermore, studying the genes associated with genetic syndromes will help doctors better understand the systems involved in the disease (20).

By conducting further investigations on a larger number of families, it will be possible to determine the prevalence and types of gene mutations involved in skin diseases in Iran. This could lead to the design of a specialized panel for ichthyoses, which would greatly assist in diagnosing the disease, preventing new cases within families, and improving overall community health.

5.1. Conclusions

Our study identified the NIPAL4 gene as a candidate gene inherited in an autosomal recessive manner, highlighting its potential involvement in Autosomal Recessive Congenital Ichthyosis (ARCI). While comprehensive genetic exploration focusing on the NIPAL4 gene family in Iran remains limited, advancements in Next-Generation Sequencing (NGS) techniques offer promising avenues for identifying and understanding genodermatoses like ichthyoses. The use of Whole Exome Sequencing (WES) has shown promise as a primary diagnostic tool, revolutionizing our ability to elucidate the genetic basis of skin diseases.

Acknowledgements

References

  • 1.

    Gutierrez-Cerrajero C, Sprecher E, Paller AS, Akiyama M, Mazereeuw-Hautier J, Hernandez-Martin A, et al. Ichthyosis. Nat Rev Dis Primers. 2023;9(1):2. [PubMed ID: 36658199]. https://doi.org/10.1038/s41572-022-00412-3.

  • 2.

    Wells RS, Kerr CB. Genetic classification of ichthyosis. Arch Dermatol. 1965;92(1):1-6. [PubMed ID: 11850936]. https://doi.org/10.1001/archderm.1965.01600130007001.

  • 3.

    Ramadon D, McCrudden MTC, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Deliv Transl Res. 2022;12(4):758-91. [PubMed ID: 33474709]. [PubMed Central ID: PMC7817074]. https://doi.org/10.1007/s13346-021-00909-6.

  • 4.

    Mazereeuw-Hautier J, Dreyfus I, Barbarot S, Serrentino L, Bourdon-Lanoy E, Ezzedine K, et al. Factors influencing quality of life in patients with inherited ichthyosis: a qualitative study in adults using focus groups. Br J Dermatol. 2012;166(3):646-8. [PubMed ID: 22014001]. https://doi.org/10.1111/j.1365-2133.2011.10701.x.

  • 5.

    Shwayder T. Disorders of keratinization: diagnosis and management. Am J Clin Dermatol. 2004;5(1):17-29. [PubMed ID: 14979740]. https://doi.org/10.2165/00128071-200405010-00004.

  • 6.

    Joosten MDW, Clabbers JMK, Jonca N, Mazereeuw-Hautier J, Gostynski AH. New developments in the molecular treatment of ichthyosis: review of the literature. Orphanet J Rare Dis. 2022;17(1):269. [PubMed ID: 35840979]. [PubMed Central ID: PMC9287901]. https://doi.org/10.1186/s13023-022-02430-6.

  • 7.

    Takeichi T, Akiyama M. Inherited ichthyosis: Non-syndromic forms. J Dermatol. 2016;43(3):242-51. [PubMed ID: 26945532]. https://doi.org/10.1111/1346-8138.13243.

  • 8.

    Yoneda K. Inherited ichthyosis: Syndromic forms. J Dermatol. 2016;43(3):252-63. [PubMed ID: 26945533]. https://doi.org/10.1111/1346-8138.13284.

  • 9.

    Saito R, Boyce A, Hsu CK, Rashidghamat E, Hide M, Wedgeworth EK, et al. Predictive phenotyping of inherited ichthyosis by next-generation DNA sequencing. Br J Dermatol. 2017;176(1):249-51. [PubMed ID: 27291450]. https://doi.org/10.1111/bjd.14807.

  • 10.

    Scott CA, Plagnol V, Nitoiu D, Bland PJ, Blaydon DC, Chronnell CM, et al. Targeted sequence capture and high-throughput sequencing in the molecular diagnosis of ichthyosis and other skin diseases. J Invest Dermatol. 2013;133(2):573-6. [PubMed ID: 22992804]. https://doi.org/10.1038/jid.2012.332.

  • 11.

    Takeichi T, Nanda A, Liu L, Salam A, Campbell P, Fong K, et al. Impact of next generation sequencing on diagnostics in a genetic skin disease clinic. Exp Dermatol. 2013;22(12):825-31. [PubMed ID: 24279917]. https://doi.org/10.1111/exd.12276.

  • 12.

    Park JS, Saeidian AH, Youssefian L, Kondratuk KE, Pride HB, Vahidnezhad H, et al. Inherited ichthyosis as a paradigm of rare skin disorders: Genomic medicine, pathogenesis, and management. J Am Acad Dermatol. 2023;89(6):1215-26. [PubMed ID: 35963288]. https://doi.org/10.1016/j.jaad.2022.08.012.

  • 13.

    Ahmad F, Ansar M, Mehmood S, Izoduwa A, Lee K, Nasir A, et al. A novel missense variant in the PNPLA1 gene underlies congenital ichthyosis in three consanguineous families. J Eur Acad Dermatol Venereol. 2016;30(12):e210-3. [PubMed ID: 26691440]. [PubMed Central ID: PMC5093081]. https://doi.org/10.1111/jdv.13540.

  • 14.

    Ahmad F, Ahmed I, Alam Q, Ahmad T, Khan A, Ahmad I, et al. Variants in the PNPLA1 Gene in Families with Autosomal Recessive Congenital Ichthyosis Reveal Clinical Significance. Mol Syndromol. 2021;12(6):351-61. [PubMed ID: 34899144]. [PubMed Central ID: PMC8613620]. https://doi.org/10.1159/000516943.

  • 15.

    Xintong Z, Kexin Z, Junwen W, Ziyi W, Na L, Hong G. Whole-exome sequencing enables rapid and prenatal diagnosis of inherited skin disorders. BMC Med Genomics. 2023;16(1):193. [PubMed ID: 37605172]. [PubMed Central ID: PMC10440863]. https://doi.org/10.1186/s12920-023-01628-2.

  • 16.

    Vahidnezhad H, Youssefian L, Jazayeri A, Uitto J. Research Techniques Made Simple: Genome-Wide Homozygosity/Autozygosity Mapping Is a Powerful Tool for Identifying Candidate Genes in Autosomal Recessive Genetic Diseases. J Invest Dermatol. 2018;138(9):1893-900. [PubMed ID: 30143075]. https://doi.org/10.1016/j.jid.2018.06.170.

  • 17.

    Sitek JC, Kulseth MA, Rypdal KB, Skodje T, Sheng Y, Retterstol L. Whole-exome sequencing for diagnosis of hereditary ichthyosis. J Eur Acad Dermatol Venereol. 2018;32(6):1022-7. [PubMed ID: 29444371]. https://doi.org/10.1111/jdv.14870.

  • 18.

    Charfeddine C, Laroussi N, Mkaouar R, Jouini R, Khayat O, Redissi A, et al. Expanding the clinical phenotype associated with NIPAL4 mutation: Study of a Tunisian consanguineous family with erythrokeratodermia variabilis-Like Autosomal Recessive Congenital Ichthyosis. PLoS One. 2021;16(10). e0258777. [PubMed ID: 34669720]. [PubMed Central ID: PMC8528321]. https://doi.org/10.1371/journal.pone.0258777.

  • 19.

    Momen LT, Abdolmaleki A, Asadi A, Zahri S. Characterization and biocompatibility evaluation of acellular rat skin scaffolds for skin tissue engineering applications. Cell Tissue Bank. 2024;25(1):217-30. [PubMed ID: 37660321]. https://doi.org/10.1007/s10561-023-10109-w.

  • 20.

    Al-Zaidi HM, Mousavinasab F, Radseresht N, Mirzaei A, Moradi Y, Mahmoudifar M. Investigation of GJB2 and SLC26A4 genes related to pendred syndrome genetic deafness patients. J Cell Mol Biomed Rep. 2023;3(2):163-71. https://doi.org/10.55705/cmbr.2023.379262.1093.